- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2024
- 343 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- March 2023
- 147 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- January 2024
- 156 Pages
United States
€3328EUR$3,800USD£2,889GBP
- Report
- January 2024
- 114 Pages
United States
€3065EUR$3,500USD£2,661GBP
Levalbuterol is a bronchodilator drug used to treat asthma and other respiratory conditions. It is a short-acting beta-2 agonist, meaning it works by relaxing the muscles in the airways, allowing more air to flow through. It is often used as a rescue medication for acute asthma attacks, and is also used to treat chronic obstructive pulmonary disease (COPD). Levalbuterol is available in both oral and inhalation forms, and is often used in combination with other medications.
Levalbuterol is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the companies that produce levalbuterol include GlaxoSmithKline, Merck, Mylan, and Teva Pharmaceuticals. Show Less Read more